98%
921
2 minutes
20
Background: Research on gustatory dysfunction among older adults has been scarce relative to research on olfactory dysfunction, and the relationship between subjective and objective gustatory dysfunction has not been studied in detail. We aimed to evaluate whether subjective recognition of gustatory dysfunction correlates with objective diagnosis of gustatory dysfunction among older adults.
Methods: In this retrospective, cross-sectional study, we reviewed the medical records of 138 patients of ages ≥ 60 years for whom data were available on self-reported and objectively measured gustatory and olfactory function from January 2018 through April 2021 at a specialized smell/taste center of a single institution. We reviewed self-reported and measured outcomes of gustatory and olfactory function using patient data including clinical characteristics, including age, sex, smoking history, and medical history.
Results: We found that the subjective recognition of gustatory dysfunction does not correlate with the objective diagnosis of gustatory dysfunction based on the measured results of gustatory function tests. Subjective gustatory dysfunction, however, was correlated with subjective olfactory dysfunction. Among clinical and demographic characteristics, age and sex were significantly associated with measured gustatory function outcomes.
Conclusion: We suggest that subjective gustatory dysfunction underestimates objective dysfunction and recommend that older men with diminished olfactory function undergo gustatory function testing regardless of their self-reported gustatory function status.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887822 | PMC |
http://dx.doi.org/10.1186/s12877-023-03781-w | DOI Listing |
Biomedicines
July 2025
Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
: Taste dysfunction is a highly prevalent yet underrecognized complication among patients with head and neck cancer (HNC), significantly impairing nutritional intake, treatment adherence, and quality of life (QoL). This comprehensive review synthesizes current knowledge on the pathophysiological mechanisms and clinical management of taste dysfunction associated with HNC and its treatments, particularly chemotherapy and radiotherapy. : A structured literature search was performed across PubMed, Scopus, and Cochrane Library for articles published between January 2015 and February 2025.
View Article and Find Full Text PDFMol Hum Reprod
August 2025
Department of Laboratory Animal Science, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China.
Recently, the expression of bitter taste receptors and their downstream taste signaling cascade have been widely found outside the gustatory system, indicating important physiological functions of bitter taste receptors in various extraoral organs including testis, but little is known about their functions in spermatogenesis. Here, we describe the localization and expression pattern of taste signaling transduction molecules in the testis. Genetic mutation of bitter signaling transduction molecules decreased the litter size, the IVF rate and the diameter of seminiferous tubules and even resulted in empty seminiferous tubules.
View Article and Find Full Text PDFPhysiol Behav
August 2025
Department of Food Science and Nutrition, Keimyung University, Dalseo-gu, Daegu, South Korea. Electronic address:
A decline in chemosensing is commonly observed in the aging process including neurodegenerative disease, however studies regarding taste sensitivity and cognitive impairment are in lacked. This study examined whether cognitive impairment is associated with gustatory dysfunction in elderly Koreans. A total of 310 Koreans from Korean Genome and Epidemiology Study - Cardiovascular Disease Association Study were analyzed to assess their cognitive function and gustatory function.
View Article and Find Full Text PDFEur J Neurol
August 2025
Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Background: Myasthenia gravis (MG) is an autoimmune disorder affecting the neuromuscular junction (NMJ), driven by T cells, mediated by B cells, and dependent on autoantibodies. In addition to the typical motor symptoms of fluctuating weakness, the non-motor symptoms are also prevalent among MG patients. This review aims to present the non-motor symptoms of MG and their potential pathogenesis, hoping to contribute to personalized diagnosis and treatment.
View Article and Find Full Text PDF